Artificial Intelligence
Medical Image Processing Deep Learning Market, 2030
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) — The “Deep Learning Market: Focus on Medical Image Processing, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.
The ‘Deep Learning Market: Focus on Medical Image Processing, 2020-2030’ report features an extensive study on the current market landscape offering an informed opinion on the likely adoption of such solutions over the next decade. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
One of the key objectives of this report was to estimate the existing market size and the future growth potential within the deep learning market (medical image processing segment), such as global radiology spending across countries, number of radiologists employed across different regions of globe, annual salary of radiologists, rate of adoption of deep learning-based solutions, we have developed informed estimates on the financial evolution of the market, over the period 2020-2030.
The report also provides details on the likely distribution of the current and forecasted opportunity across [A] application area (lung infections/respiratory disorders, brain injuries/disorders, lung cancer, cardiac conditions/cardiovascular disorders, bone deformities/orthopedic disorders, breast cancer and others), [B] type of image processed (X-ray, MRI, CT, ultrasound) and [C] region (North America, Europe and Asia Pacific/Rest of the World).
In order to account for future uncertainties and to add robustness to our forecast model, we have provided three scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
The report features detailed transcripts of interviews held with the following individuals (in alphabetical order):
- Walter de Back (Research Scientist, Context Vision, Q2 2020)
- Dr. Vikas Karade (CEO, AlgoSurg, Q2 2020)
- Babak Rasolzadeh (Senior Director of Product, Arterys, Q2 2020)
- Carla Leibowitz, (Head of Strategy and Marketing, Arterys, Q2 2017)
- Mausumi Acharya, (CEO, Advenio Technosys, Q2 2017)
- Deekshith Marla, (CTO, Arya.ai) and Sanjay Bhadra, (COO, Arya.ai, Q2 2017)
Key Topics Covered:
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Humans, Machines and Intelligence
3.2. The Science of Learning
3.3. Artificial Intelligence
3.4. The Big Data Revolution
3.5. Applications of Deep Learning in Healthcare
4. CASE STUDY: IBM WATSON VERSUS GOOGLE DEEPMIND
4.1. Chapter Overview
4.2. International Business Machines (IBM)
4.3. Google
4.4. IBM versus Google: Artificial Intelligence-related Acquisitions
4.5. IBM versus Google: Healthcare Focused Partnerships and Collaborations
4.6. IBM versus Google: Primary Concerns and Future Outlook
5. MARKET OVERVIEW
5.1. Chapter Overview
5.2. Deep Learning in Medical Image Processing: Overall Market Landscape
5.3. Deep Learning in Medical Image Processing: Information on Key Characteristics
5.4. Deep Learning in Medical Image Processing: List of Companies
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Artelus
6.3. Arterys
6.4. Butterfly Network
6.5. ContextVision
6.6. Enlitic
6.7. Echonous
6.8. GE Healthcare
6.9. InferVision
6.10. VUNO
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Deep Learning in Medical Image Processing: List of Partnerships and Collaborations
7.4. Concluding Remarks
8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Types of Funding
8.3. Deep Learning in Medical Image Processing: Recent Funding Instances
9. COMPANY VALUATION ANALYSIS
9.1. Chapter Overview
9.2. Methodology
9.3. Categorization by Parameters
10. CASE STUDY: ANALYSIS OF DEEP LEARNING-BASED CLINICAL TRIALS REGISTERED IN THE US
10.1. Chapter Overview
10.2. Scope and Methodology
10.3 Clinical Trial Analysis
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Deep Learning and Medical Image Processing: Patent Analysis
11.4. Patent Valuation Analysis
12. COST SAVING ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Overall Cost Saving Potential of Deep Learning in Medical Image Processing Solutions, 2020-2030
12.4. X-Ray Images
12.5. MRI Images
12.6. CT Images
12.7. Ultrasound Images
12.8. Concluding Remarks: Cost Saving Scenarios
13. MARKET FORECAST
13.1. Chapter Overview
13.2 Forecast Methodology and Key Assumptions
13.3 Overall Deep Learning in Medical Image Processing Market
13.3 Deep Learning in Medical Image Processing Market: Distribution by Application Area
13.4 Deep Learning in Medical Image Processing Market: Distribution by Type of Image Processed
13.5 Deep Learning in Medical Image Processing Market: Distribution by Key Geographical Regions
13.6 Concluding Remarks
14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS
14.1. Chapter Overview
14.2. Industry Experts
14.3. University and Hospital Experts
14.4. Other Expert Opinions
15. INTERVIEW TRANSCRIPTS
15.1 Chapter Overview
15.2. Advenio Technosys
15.3. Arterys
15.4. Arya.ai
15.5. AlgoSurg
15.6. ContextVision
16. IMPACT OF COVID-19 OUTBREAK ON DEEP LEARNING MARKET DYNAMICS
16.1. Chapter Overview
16.2. Evaluation of Impact of COVID-19 Pandemic
16.3. Response Strategies: A Perspective
17. CONCLUSION
18. APPENDIX 1: TABULATED DATA
Companies Mentioned
- 8VC
- Accel
- Acequia Capital
- Advantech Capital
- Advenio Technosys
- Aetion
- Affidea
- Agfa HealthCare
- AiCure
- Aidence
- Aidoc
- Alberta Innovates
- AlbionVC
- AlchemyAPI
- Alder Hey Children’s Hospital
- AlgoMedica
- AlgoSurg
- Allen Institute for AI
- ALMatter
- Almaworks
- Amazon Web Services
- AME Cloud Ventures
- AME Cloud Ventures
- American Cancer Society
- American Diabetes Association
- American Heart Association
- American Sleep Apnea Association
- aMoon
- Amplify Partners
- Analytics Ventures
- Anand Diagnostic Laboratory
- Anthem
- Antwerp University Hospital (UZA)
- Apollo Hospitals
- Apple
- Apposite Capital
- Artelus
- Arterys
- Arya.ai
- Asan Medical Center
- Asset Management Ventures
- AT&T Labs
- Atomico
- Atrium Health
- Aurum
- Avicenna
- Axilor Ventures
- Ayce Capital
- AZ Maria Middelares
- Baidu.ventures
- Baillie Gifford
- Bar-llan University
- Behold.ai
- Beijing Dongfang Hongtai Technology
- Beijing Hao Yun Dao Information & Technology (Paiyipai)
- BenevolentAI
- Benslie Investment Group
- BI INVESTMENTS
- Bill & Melinda Gates Foundation
- BinomixRay
- Bioinfogate
- Biotechnology Industry Research Assistance Council (BIRAC)
- Blackford Analysis
- BlueCross BlueShield Venture
- Boca Raton Regional Hospital
- Boehringer Ingelheim
- Boehringer Ingelheim
- Bold Brain Ventures
- Bold Capital Partners
- Bolton NHS Foundation Trust
- Boston Children’s Hospital
- Brainomix
- Bridge Bank
- Bridge to Health USA
- Buckinghamshire Healthcare NHS Trust
- Business Development Bank of Canada (BDC)
- Butterfly Network
- Cadens Medical Imaging
- Campus Bio-Medico University Hospital
- Canon Medical Systems
- Capital Health
- Capitol Health
- Capricorn Partners
- Caption Health
- Carestream Health
- CDH Investments
- Cedars-Sinai
- Cemag Invest
- Cenkos Securities
- Centre for Advanced Research in Imaging
- ChainZ Medical Technology
- Change Healthcare
- Chimera Partners
- Chiratae Ventures
- Chiratae Ventures (Formerly IDG Ventures)
- Clalit Research Institute
- Cleveland Clinic
- Clever Sense
- Cloud DX
- Co-Diagnostics
- Cognea
- Connect Ventures
- Connecticut Innovations
- ContextVision
- CorTechs Labs
- Cota Capital
- Crouse Health
- CRV (acquired by Microsoft)
- Ctrip
- CuraCloud
- CureMetrix
- Danhua Capital (DHVC)
- Daotong Capital
- Dark Blue Labs
- Dartford and Gravesham NHS Trust
- Dartmouth College
- Data Collective
- Data Collective (DCVC)
- Dataminr
- Deep Genomics
- DeepMind
- DeepTek
- Deepwise
- DEFTA Partners
- Dell
- DePuy Synthes
- DiA Imaging Analysis
- DigitalOcean
- DNA Capital
- DNNresearch
- doc.ai
- DocPanel
- Dolby Family Ventures
- Dong Kook Lifescience
- Dr. Susan Love Foundation for Breast Cancer Research
- Dubai Diabetes Center
- Duke University
- East Seattle Partners
- EBSCO
- EchoNous
- Edan Instruments
- Edwards Lifesciences
- eInfochips
- Elekta
- Emergent Connect
- Emergent Medical Partners
- Emu Technology
- Endiya Partners
- Enlitic
- Erlanger Health System
- European Commission
- Exigent Capital Group
- Exilant Technologies
- Exor
- Explorys, an IBM Company
- Fang Danhua Capital
- fast.ai
- FbStart
- FemtoDx
- Fertility Road
- ff Venture Capital
- Fidelis Care
- Fidelity Investments
- FIDI (Imaging Diagnostic Research Institute Foundation)
- Forestay Capital
- Forge
- Formation 8
- Fosun RZ Capital
- Founder Friendly Labs (FFL)
- Fractal Analytics
- Frazier Healthcare Partners
- Froedtert & the Medical College of Wisconsin Cancer Network
- Frost Data Capital
- Fujifilm Medical Systems USA
- FUJIFILM Sonosite
- Fujita Health University
- Future Play Green Cross Holdings
- Fysicon
- Gachon University Gil Medical Center
- GE Healthcare
- GE Ventures
- Genentech
- gener8tor
- General City Hospital, Aalst
- Genesis Capital Advisors
- Georges Harik
- GF Securities
- Google Ventures
- Government of Canada
- Granata Decision Systems (acquired by Google)
- Green House Ventures (GHV) Accelerator
- Greenbox Venture Partners
- Greenoaks Capital
- Greycroft
- Guerbet
- Haitong Leading Capital Management
- Halli Labs
- HALO Diagnostics
- Hanfor Capital Management
- Hangzhou CognitiveCare
- Harrow Council
- HB Investment
- Health Innovations
- HealthKonnect India
- HealthNet Global
- HeartFlow
- HelpAround
- henQ
- Hera Investment Funds
- Herman Verrelst
- Highmark Health
- Holland Capital
- Hongdao Capital
- Hoxton Ventures
- HTC
- Huntington Hospital
- Hyundai Investment Partners
- IBM
- iCAD
- icometrix
- iLabs Capital
- Illumina
- IMADIS Teleradiologie
- Imagia Cybernetics
- Imaging Biometrics
- Imbio
- ImFusion
- IMM Investment
- Imperial College London
- Incepto
- Indira IVF
- Infervision
- InHealth
- INKEF Capital
- In-Med Prognostics
- Innova Salud
- Innovacom
- Innovate UK
- Innovation Endeavors
- InnovationQuarter
- Institut Curie
- Institute for Data Valorization (IVADO)
- Intel
- Intelerad Medical Systems
- Intelligent Ultrasound
- Intermountain Healthcare
- Intervest
- Intrasense
- Invenshure
- IQ Capital
- iSchemaView (RapidAI)
- iSono Health
- Israel Innovation Authority
- Jetpac (Justice Education Technology Political Advocacy Center)
- Johns Hopkins University
- Johnson & Johnson
- joule
- Kaggle
- Kakao Ventures
- Karos Health
- KB Investment
- Kentuckiana Health Collaborative (KHC)
- Keshif Ventures
- Kheiron Medical Technologies
- Khosla Ventures
- Kinzon Capital
- Kinzon Capital
- Kleiner Perkins
- Koinvesticinis Fondas
- Koios Medical
- Konica Minolta
- Korea Development Bank
- Korea Telecom
- Kt Investments
- Kumamoto University
- L2 Ventures
- La Costa Investment Group
- Legend Capital
- Lenovo
- Lenovo
- LG CNS
- Linkoping University
- LPIXEL
- LucidHealth
- Lumenis
- Luminous Ventures
- Lunit
- M3
- Maccabi Healthcare Services
- Mach7 Technologies
- Manipal Hospitals
- Marubeni
- MassMutual Ventures (MMV)
- MaxQ AI
- Mayo Clinic
- MBM Company
- McGill University
- MD Anderson Cancer Center
- MedAxiom
- MedGlobal
- Medica Superspecialty Hospital
- Mediscan Systems
- MEDNAX
- MedNetwork
- MEDO.ai
- Medsynaptic
- MEDTEQ
- Medtronic
- Merge Healthcare
- Methinks
- Microsoft
- Mindshare Medical
- Minneapolis Heart Institute Ventures
- Mirada Medical
- Mirae Asset Venture Investment
- MLP Care
- Monash IVF
- Montefiore Nyack Hospital
- Montreal Institute for Learning Algorithms (MILA)
- Moodstocks
- Moorfields Eye Hospital
- Morado Venture Partners
- Mount Sinai Hospital
- Myongji Hospital
- Nanox
- National Health Service (NHS) Trust
- National Imaging Academy Wales
- National Institute of General Medical Sciences
- National Institutes of Health
- National Science Foundation
- Nauto
- NeuralSeg
- New York Genome Center (NYGC)
- New York University (NYU)
- NewMargin Ventures
- NewYork-Presbyterian Hospital
- Nico.lab
- Nightingale Hospital
- Nines
- NMC Healthcare
- Nobori
- Nordic Medtech
- Northwell Health
- Northzone
- Norwich Ventures
- Novo Nordisk
- NTT DATA
- Nuance Communications
- NVIDIA
- NXC Imaging
- Nyansa (now a part of VMware)
- ODH Solutions
- Olea Medical
- Optellum
- Optina Diagnostics
- Optum Ventures
- ORI Capital
- OurCrowd
- Ovation Fertility
- Oxipit
- Panorama Point Partners
- Parkwalk Advisors
- Partners HealthCare
- Pathway Genomics
- Pentathlon Ventures
- Philips
- Phytel, An IBM Company
- pi Ventures
- platform.ai
- PointGrab
- PowerCloud Venture Capital
- Practica Capital
- Prairie Cardiovascular
- Precision Vascular
- Presence Capital
- Qiming Venture Partners
- Qingsong Fund
- Qualcomm Design
- Quantib
- Quest Diagnostics
- QuEST Global
- QUIBIM
- Qure.ai
- Rabo Ventures
- RADLogics
- RaySearch Laboratories
- Realize
- Red Hat
- Regal Funds Management
- Revelation Partners
- Rhon-Klinikum
- Riverain Technologies
- Roche
- Royal Berkshire NHS Foundation Trust
- Royal United Hospitals
- R-Pharm
- Samsung
- San Raffaele Hospital
- Sana Kliniken
- Satis Operations
- SB Investment
- SBRI Healthcare
- ScreenPoint Medical
- SeeAI
- Segunda Lectura Diagnostica
- Sejong Hospital
- SELECT Healthcare Solutions
- SEMA Translink Investment
- SemanticMD
- Semmelweis University
- Sentient Technologies
- Seoul National University Hospital
- Sequoia Capital
- ShengJing360
- Shinhan Investment
- Siemens Healthineers
- SigTuple
- Skope Magnetic Resonance Technologies
- Smilegate Investment
- SoftBank Ventures Asia
- SpaceX
- Square Peg Capital
- SRI Ventures
- St. John’s College
- Stanford University
- StartX
- Subtle Medical
- Sunland Fund
- Sunshine Insurance Group
- Taihe Capital
- Tech Transfer UPV
- Tekes – the Finnish Funding Agency for Technology and Innovation
- Telemedicine Clinic
- Telerad Tech
- Temasek
- Temecula Valley Hospital
- Tencent
- TeraRecon
- Terason
- Teva Pharmaceuticals
- Texas Medical Center
- The Alan Turing Institute
- The American College of Radiology (ACR) Data Science Institute(DSI)
- The Inventor’s Guild
- The Israel Innovation Authority
- The Jagen Group
- The Oncopole
- The Scottish Government
- The Venture Reality Fund
- Thorney Investment Group
- Threshold Ventures
- Tiatros
- Timeful (acquired by Google)
- TLV Partners
- Tongdu Capital
- Tracxn Technologies
- Trakterm
- Trillium Health Partners
- Trusted Insight
- Truven Health Analytics
- Tsingyuan Ventures
- Twitter Cortex
- University of Antwerp
- University of Bordeaux
- University of California
- University of Cambridge
- University of Dundee
- University of Edinburgh
- University of Florida
- University of Hertfordshire
- University of Montreal
- University of Oxford
- University of Oxford
- University of San Francisco
- University of Sheffield
- UW Medicine
- Varian Medical Systems
- VH Capital
- Vision Factory
- Vivo
- Viz.ai
- Vizyon
- Volpara Solutions
- VoxelCloud
- VUNO
- Wavemaker Partners
- WeDoctor
- Wellbeing Software
- Wellington Management
- Wisemont Capital
- Wish
- Women’s Imaging Associates
- XB Ventures
- Xiang He Capital
- Y Combinator
- Yongin Severance Hospital
- Zebra Medical Vision
- ZhenFund
For more information about this report visit https://www.researchandmarkets.com/r/q4vt1o
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Artificial Intelligence
Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth Solutions In Hospital Rooms
MARKHAM, ON, April 25, 2024 /PRNewswire/ — Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings.
SONIFI Health is a leading U.S. healthcare technology company based in Sioux Falls, South Dakota. The new partnership leverages and integrates Enghouse Video room systems technology to support SONIFI Health’s commitment to expanding telehealth applications and system optimizations in hospital settings.
Enghouse’s VidyoRooms solution, a sophisticated video conferencing technology that combines both software and hardware solutions, has been fully integrated into SONIFI Health’s interactive TV systems. This integration provides up to 4K high-quality video conferencing, multi-party sessions and robust security features that ensure full compliance with healthcare regulations.
Enghouse Video offers an immersive telehealth platform to support collaborative interdisciplinary care, improved patient outcomes and cost savings. The platform is flexible and simple, delivering the reliability, interoperability, and scalability needed for today’s healthcare environment. A key strength of the partnership is its offering of back-end integrations like patient portals, medical devices, EMR, tele-sitting, remote patient observation and consultation.
“Hospitals can choose the telehealth partner that’s right for them, and we incorporate that solution with interactive TV,” said Brian Nido, SONIFI Health’s Vice President of Customer Success. “Using the hardware and systems they already have in patient rooms helps hospitals reduce costs and maximize the value of their existing investments, while benefiting both clinicians and patients.”
SONIFI Health and Enghouse Video continue to collaborate closely to further refine and enhance the telehealth solutions provided to healthcare facilities. This partnership reflects a shared commitment to leveraging technology to create smarter hospital rooms and improve patient care across the healthcare spectrum.
About Enghouse VideoEnghouse Video, part of the Enghouse Interactive division, is a subsidiary of Enghouse Systems Limited, a vertically focused software and services company traded on the Toronto Stock Exchange (TSX: ENGH). Through highly secure, scalable and flexible Cloud-based or On Prem services, we deliver one of the world’s highest quality and most innovative video platform to video-enable any application or idea. From advanced video conferencing and collaboration tools to state-of-art enterprise video management, Enghouse Video is a unique player in multiple markets, including telehealth. Learn more at www.enghousevideo.com, read our blog, or follow us on Twitter at @EnghouseVideo, on LinkedIn, and on Facebook.
About SONIFI HealthSONIFI Health provides market-leading interactive patient engagement technology proven to improve patient outcomes and staff productivity. The EHR-integrated platform is designed to enhance patient and family experiences while increasing staff satisfaction and organizations’ operational efficiencies. As part of SONIFI Solutions, Inc., the company annually supports more than 300 million end user experiences. Learn more at sonifihealth.com.
Enghouse Video Contact: Sylvain Awad, Director, Demand Generation, Enghouse Video, part of Enghouse Interactive Division, [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/enghouse-video-partners-with-sonifi-health-to-deliver-advanced-telehealth-solutions-in-hospital-rooms-302126882.html
Artificial Intelligence
Global Insurance Provider Selects 3CLogic to Streamline AI and Contact Center Capabilities with ServiceNow
Multinational Insurance Broker to deploy 3CLogic’s solution with ServiceNow’s Financial Service Operations (FSO) platform to streamline customer experiences.
ROCKVILLE, Md., April 25, 2024 /PRNewswire/ — 3CLogic, the leading Conversational AI and Contact Center solution for ServiceNow®, today announced its selection by a global insurance provider to replace its existing contact center infrastructure as part of a larger CX transformation effort. The strategic decision is designed to complement the organization’s use of ServiviceNow’s Financial Services Operations (FSO) offering leveraged across a number of its existing product lines including Customer Warranty Claims, Roadside Assistance, and Home Warranties.
Serving millions of customers worldwide with innovative insurance and protective products, the organization required a solution that would enhance its recent investment in the ServiceNow platform as it works to transform its end-to-end customer service operations. The deployment will incorporate several of 3CLogic’s AI-powered capabilities purpose-built for ServiceNow, including Conversational AI, Speech Analytics, and AI Performance & Coaching, along with integrated call transcriptions, convenient 2-way SMS, and ServiceNow-centralized contact center reporting.
“We continue to see enterprises eager to complement their existing investment in digital platforms, such as ServiceNow, with contact center features purpose-built to extend the workflows and features they already have and use,” explains Matt Durkin, VP of Global Sales at 3CLogic. “It’s no secret that organizations are already juggling too many systems, often with overlapping capabilities, which impacts ROI and operational efficiency. We’re proud to offer an alternative approach that helps simplify the technology stack while optimizing the overall operational costs and outcomes.”
Recently named to Constellation Research’s 2024 Shortlist for Digital Customer Service and Support, 3CLogic has seen global adoption of its solution by leading enterprises in healthcare, manufacturing, travel, retail, higher education, finance, non-profits, and Managed Service Providers across five continents. As a ServiceNow-certified Technology and Build partner with offerings available for ServiceNow’s IT Service Management, Customer Workflows, HR Service Delivery, and Source-to-Pay solutions, the company will be unveiling its latest set of capabilities at ServiceNow’s annual Knowledge 2024 event this May in Las Vegas.
For more information, please contact [email protected].
About 3CLogic3CLogic transforms customer and employee experiences with its leading Cloud Contact Center and AI solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative features such as intelligent self-service, generative and Conversational AI, agent automation & coaching, and AI-powered sentiment analytics – all designed to lower operational costs, maximize ROI, and optimize each interaction across IT Service Desks, Customer Support, Sales or HR Services teams. For more information, please visit www.3clogic.com.
Logo – https://mma.prnewswire.com/media/2318845/3CLogic_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow-302127739.html
Artificial Intelligence
ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO
Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO
NIJMEGEN, Netherlands, April 25, 2024 /PRNewswire/ — ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint’s commercial growth and success over the past 2 years.
The company’s Board of Directors has appointed Pieter Kroese as the new Chief Executive Officer effective April 25, 2024. Pieter takes the role after serving as COO of ScreenPoint for over five years. During that time, he has managed the transition of the company from an early startup to a thriving enterprise with hundreds of customers using ScreenPoint’s flagship Transpara software to support millions of scans a year.
“I am thrilled to lead ScreenPoint into its next phase of growth and innovation,” said Mr. Kroese. “I am deeply committed to building upon the strong foundation we have and continuing to work closely with our talented team to drive continued success. We are already expanding screening capacity and capability through proven reader support – we look forward to increasing our ability to support providers and women moving forward.”
Sir Michael Brady, Chairman of the Board at ScreenPoint Medical and a co-founder of the company, expressed enthusiasm about Pieter’s appointment, stating, “Pieter’s remarkable leadership qualities, coupled with his depth of knowledge of our product and industry, make him the perfect choice to lead ScreenPoint into the future. His strategic mindset and commitment to excellence align perfectly with our company mission of early breast cancer detection. Pieter has been an integral part of our growth to date and will provide seamless leadership through this transition into our next chapter for our customers, partners, and team.”
Author of “No Longer Radical” and over a hundred peer-reviewed publications on breast imaging, Dr. Rachel Brem is a Transpara user and ScreenPoint Board Member. Dr. Brem welcomed Mr. Kroese with the following: “Pieter has been an integral part of the ScreenPoint team for years. I am confident that his leadership will continue to deliver product excellence: earlier detection with outstanding reading workflow and improved patient outcomes. We continue to see these results from clinical sites all over the world, including many here in the United States. No other Breast AI solution has demonstrated the same results as Transpara, and I am confident that the team will continue to push on these frontiers under Pieter’s leadership.”
The entire team at ScreenPoint extends its gratitude to Mark Koeniguer and wishes him every success in the future, while warmly welcoming Pieter Kroese into his new role as CEO.
About ScreenPoint Medical
ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment. Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers.
See all the proof at: https://screenpoint-medical.com/evidence.
Photo: https://mma.prnewswire.com/media/2397831/Pieter_Kroese_CEO_ScreenPoint_Medical.jpgLogo: https://mma.prnewswire.com/media/1582198/ScreenPoint_Medical_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/screenpoint-medical-leadership-transition-pieter-kroese-confirmed-as-ceo-302127719.html
-
Uncategorized7 days ago
Generative AI gold rush drives IT spending — with payoff in question
-
Uncategorized7 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized7 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized7 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Artificial Intelligence6 days ago
Free Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
-
Uncategorized7 days ago
Can artificial intelligence reduce vehicle time to market?
-
Uncategorized7 days ago
The Ottawa Hospital doctors to try AI for patient notes
-
Artificial Intelligence6 days ago
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions